Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira. Fred Katayama reports.
Peoples are using these keywords: acquisition, Acquisitionallergan, pharma, merger, Botox, Rob cyran, Pfizer, deal, Humira, Abbvie, Allergan

You might also like this


Please enter your comment!
Please enter your name here